Ownership

Andrew Reardon - CLO & Secretary at Ligand Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: CLO & Secretary
Stock Symbol: LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Andrew Reardon - trading volume in the past year for Ligand Pharmaceuticals Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-13.5K	100%	$88.09	-$1.19M
Net	-13.5K	-100%		-$1.19M

Holdings reported by Andrew Reardon for Ligand Pharmaceuticals Inc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	34.8K	$4M	$115.03	Mar 4, 2025	Direct
Non-Qualified Stock Option (right to buy)	62.9K			May 9, 2024	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	61.4K			Aug 28, 2024	Direct	Common Stock
Employee Stock Option (right to buy)	28K			Mar 4, 2025	Direct	Common Stock

Transactions reported by Andrew Reardon for Ligand Pharmaceuticals Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.